The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease

Journal of the American College of Cardiology

Volumn 43, Issue 4, 2004, Pages 576-582

  Sachdev, Molly ^a,b   Sun, Jie Lena ^a   Tsiatis, Anastasios A ^a   Nelson, Charlotte L ^a   Mark, Daniel B ^a   Jollis, James G ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Congestive heart failure; Coronary artery disease; Left ventricular ejection fraction; Myocardial infarction

Indexed keywords

ADULT; AGED; ARTICLE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ETHNOLOGY; FACTUAL DATABASE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; KIDNEY FAILURE; LYMPHOMA; MALE; MORTALITY; NEGRO; NONBIOLOGICAL MODEL; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SURVIVAL TIME; TIME;

EID: 1242317689     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.10.031     Document Type: Article

References (13)

1. van den Akker M., Butinx F., Metsemakers J., Roos S., Knotternerus J.A. Multimorbidity in general practice Prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases . J Clin Epidemiol. 51:1998;367-375.
2. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies. J Chron Dis. 40:1987;373-383.
3. D'Hoore W., Bouckaert A., Tilquin C. Practical considerations on the use Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 49:1996;1429-1433.
4. Hlatky M.A., Califf R.M., Harrell F.E., Lee K.L., Mark D.B., Pryor D.B. Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary bypass surgery. J Am Coll Cardiol. 11:1988;237-245.
5. Mark D.B., Nelson C.L., Califf R.M., et al. The continuing evolution of therapy for coronary artery disease Initial results from the era of coronary angioplasty . Circulation. 89:1994;2015-2025.
6. SAS User's Guide, Statistics: version 6, vol. 1. 1990;SAS Institute, Cary, NC.
7. Cox D.R. Regression models and life-tables. J Roy Stat Soc. 34:1972;187-220.
8. Efron B., Tibshirani R. An Introduction to the Bootstrap. 1993;Chapman and Hill, New York, NY.
9. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease The framingham study . JAMA. 241:1979;2035-2038.
10. Barzilay J.L., Kronmal R.A., Bittner V., et al. Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease A report from the coronary artery surgery study registry . Am Heart J. 135:1998;1055-1062.
11. Cavendar J.B., Rogers W.J., Fisher L.D., et al. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS) 10-year follow-up . J Am Coll Cardiol. 20:1992;287-294.
12. Kronmal R.A., Kosinski A.S., Mock M.B. The relationship between cholesterol level and myocardial infarction or mortality risk in patients with coronary artery disease A report from the coronary artery surgery study (cass) registry . Ann Epidemiol. 2:1992;129-136.
13. Shlipak M.G., Heidenreich P.A., Noguchi H., Chertrow G.M., et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med. 137:2002;555-562.